108 related articles for article (PubMed ID: 17357536)
1. Tissue microarray-determined expression profiles of cyclooxygenase-2 in colorectal adenocarcinoma: association with clinicopathological parameters.
Wu CY; Lee WH; Wang JY; Chiang H; Chang JL; Tsai WC; Sheu LF; Jin JS
Chin J Physiol; 2006 Dec; 49(6):298-304. PubMed ID: 17357536
[TBL] [Abstract][Full Text] [Related]
2. Higher expression of epidermal growth factor receptor is associated with extracellular matrix metalloprotease inducer in colorectal adenocarcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Jin JS; Wu CY; Lin YF; Wang JY; Yu CP; Sheu LF; Chiang H; Tsai WC; Lee WH
Dis Markers; 2006; 22(5-6):309-16. PubMed ID: 17264401
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclooxygenase-2 (COX-2) in colorectal adenocarcinoma: an immunohistochemical and histopathological study.
Mahmoud AS; Umair A; Azzeghaiby SN; Alqahtani FH; Hanouneh S; Tarakji B
Asian Pac J Cancer Prev; 2014; 15(16):6787-90. PubMed ID: 25169526
[TBL] [Abstract][Full Text] [Related]
4. Correlation of COX- 2 Expression in Colorectal Carcinoma with Clinicopathological Features.
Venkatachala S; Rajendran M
Turk Patoloji Derg; 2017; 33(3):228-234. PubMed ID: 28272681
[TBL] [Abstract][Full Text] [Related]
5. 5-Lipoxygenase is coexpressed with Cox-2 in sporadic colorectal cancer: a correlation with advanced stage.
Barresi V; Grosso M; Vitarelli E; Tuccari G; Barresi G
Dis Colon Rectum; 2007 Oct; 50(10):1576-84. PubMed ID: 17762961
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of fascin-1 in advanced colorectal adenocarcinoma: tissue microarray analysis of immunostaining scores with clinicopathological parameters.
Tsai WC; Chao YC; Sheu LF; Chang JL; Nieh S; Jin JS
Dis Markers; 2007; 23(3):153-60. PubMed ID: 17473384
[TBL] [Abstract][Full Text] [Related]
7. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
[TBL] [Abstract][Full Text] [Related]
8. EphB1 is underexpressed in poorly differentiated colorectal cancers.
Sheng Z; Wang J; Dong Y; Ma H; Zhou H; Sugimura H; Lu G; Zhou X
Pathobiology; 2008; 75(5):274-80. PubMed ID: 18931529
[TBL] [Abstract][Full Text] [Related]
9. Decreased matriptase/HAI-1 ratio in advanced colorectal adenocarcinoma of Chinese patients.
Tsai WC; Sheu LF; Chao YC; Chen A; Chiang H; Jin JS
Chin J Physiol; 2007 Oct; 50(5):225-31. PubMed ID: 18274158
[TBL] [Abstract][Full Text] [Related]
10. Expression of survivin and cortactin in colorectal adenocarcinoma: association with clinicopathological parameters.
Lee YY; Yu CP; Lin CK; Nieh S; Hsu KF; Chiang H; Jin JS
Dis Markers; 2009; 26(1):9-18. PubMed ID: 19242064
[TBL] [Abstract][Full Text] [Related]
11. Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity.
Lam AK; Ong K; Ho YH
Hum Pathol; 2008 Apr; 39(4):599-604. PubMed ID: 18284933
[TBL] [Abstract][Full Text] [Related]
12. Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients.
Negi RR; Rana SV; Gupta V; Gupta R; Chadha VD; Prasad KK; Dhawan DK
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1675-1681. PubMed ID: 31244287
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evaluation of tissue-specific proteolytic enzymes in adenomas containing foci of early carcinoma: correlations with cathepsin D expression and other malignant features.
Kunimura T; Inagaki T; Wada M; Ushio J; Sato K; Enosawa T; Nakashima M; Kato H; Hayashi R; Saitou K; Morohoshi T
Int J Gastrointest Cancer; 2003; 33(2-3):149-54. PubMed ID: 14716064
[TBL] [Abstract][Full Text] [Related]
14. COX-2, inflammatory secreted PLA2, and cytoplasmic PLA2 protein expression in small bowel adenocarcinomas compared with colorectal adenocarcinomas.
Wendum D; Svrcek M; Rigau V; Boëlle PY; Sebbagh N; Parc R; Masliah J; Trugnan G; Fléjou JF
Mod Pathol; 2003 Feb; 16(2):130-6. PubMed ID: 12591965
[TBL] [Abstract][Full Text] [Related]
15. Prognostic importance of COX-2 expression in patients with colorectal cancer.
Yamac D; Celenkoglu G; Coskun U; Akyurek N; Akcali Z; Dursun A; Koybasioglu F
Pathol Res Pract; 2005; 201(7):497-502. PubMed ID: 16164044
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclooxygenase-2 protein in colorectal carcinomas.
Joo YE; Kim HS; Min SW; Lee WS; Park CH; Park CS; Choi SK; Rew JS; Kim SJ
Int J Gastrointest Cancer; 2002; 31(1-3):147-54. PubMed ID: 12622426
[TBL] [Abstract][Full Text] [Related]
17. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
[TBL] [Abstract][Full Text] [Related]
18. Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization.
Melling N; Simon R; Izbicki JR; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
Int J Clin Exp Pathol; 2015; 8(6):7009-15. PubMed ID: 26261591
[TBL] [Abstract][Full Text] [Related]
19. Age-related alteration in the association of microsatellite instability with absent hMLH1 expression and histological types of colorectal carcinoma.
Arai T; Sugai T; Kasahara I; Sawabe M; Honma N; Aida J; Nakamura S; Takubo K
Pathol Int; 2006 Oct; 56(10):597-603. PubMed ID: 16984616
[TBL] [Abstract][Full Text] [Related]
20. Association between COX-2 expression and effectiveness of COX-2 inhibitors in a phase II trial in patients with metastatic colorectal adenocarcinoma.
Almhanna K; El-Rayes B; Sethi S; Dyson G; Heilbrun L; Philip PA; Sarkar F
Anticancer Res; 2012 Aug; 32(8):3559-63. PubMed ID: 22843946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
